Almost all patients demonstrated a rapid increase in plasma HGF, reaching peak levels of POD1 in breast and colorectal cancer patients and POD3 in prostate cancer patients, consistent with other reports [123,124,125,126]. The gene discussed is HGF; the disease is prostate carcinoma.